| Antidiabetic therapies affect risk of pancreatic cancer D Li, SCJ Yeung, MM Hassan, M Konopleva, JL Abbruzzese Gastroenterology 137 (2), 482-488, 2009 | 767 | 2009 |
| Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies LM Phan, SCJ Yeung, MH Lee Cancer biology & medicine 11 (1), 1, 2014 | 572 | 2014 |
| Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b JC Yao, A Phan, PM Hoff, HX Chen, C Charnsangavej, SCJ Yeung, ... Journal of Clinical Oncology 26 (8), 1316-1323, 2008 | 502 | 2008 |
| Metformin use is associated with better survival of diabetic patients with pancreatic cancer N Sadeghi, JL Abbruzzese, SCJ Yeung, M Hassan, D Li Clinical cancer research 18 (10), 2905-2912, 2012 | 345 | 2012 |
| Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians … DE Ost, SCJ Yeung, LT Tanoue, MK Gould Chest 143 (5), e121S-e141S, 2013 | 234 | 2013 |
| Obesity-associated NLRC4 inflammasome activation drives breast cancer progression R Kolb, L Phan, N Borcherding, Y Liu, F Yuan, AM Janowski, Q Xie, ... Nature communications 7 (1), 13007, 2016 | 221 | 2016 |
| Tumor‐specific changes in mtDNA content in human cancer E Mambo, A Chatterjee, M Xing, G Tallini, BR Haugen, SCJ Yeung, ... International journal of cancer 116 (6), 920-924, 2005 | 208 | 2005 |
| Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer BA Schiff, AB McMurphy, SA Jasser, MN Younes, D Doan, OG Yigitbasi, ... Clinical cancer research 10 (24), 8594-8602, 2004 | 205 | 2004 |
| Aurora B kinase phosphorylates and instigates degradation of p53 CP Gully, G Velazquez-Torres, JH Shin, E Fuentes-Mattei, E Wang, ... Proceedings of the National Academy of Sciences 109 (24), E1513-E1522, 2012 | 191 | 2012 |
| Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells Q Jin, LX Yuan, D Boulbes, JM Baek, YN Wang, D Gomez-Cabello, ... Breast Cancer Research 12, 1-15, 2010 | 162 | 2010 |
| Roles of COP9 signalosome in cancer MH Lee, R Zhao, L Phan, SCJ Yeung Cell cycle 10 (18), 3057-3066, 2011 | 159 | 2011 |
| Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease H Abu-Sbeih, DM Faleck, B Ricciuti, RB Mendelsohn, AR Naqash, ... Journal of Clinical Oncology 38 (6), 576, 2020 | 153 | 2020 |
| Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments JM Caterino, D Adler, DD Durham, SCJ Yeung, MF Hudson, A Bastani, ... JAMA network open 2 (3), e190979-e190979, 2019 | 131 | 2019 |
| Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells SCJ Yeung, G Xu, J Pan, M Christgen, A Bamiagis Cancer research 60 (3), 650-656, 2000 | 131 | 2000 |
| Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers R Zhao, SCJ Yeung, J Chen, T Iwakuma, CH Su, B Chen, C Qu, F Zhang, ... The Journal of clinical investigation 121 (3), 851-865, 2011 | 130 | 2011 |
| Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation … W Liao, SCJ Yeung, L Chan Journal of Biological Chemistry 273 (42), 27225-27230, 1998 | 126 | 1998 |
| Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress C Yang, W Lu, T Lin, P You, M Ye, Y Huang, X Jiang, C Wang, F Wang, ... BMC gastroenterology 13, 1-14, 2013 | 125 | 2013 |
| Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells J Pan, M She, ZX Xu, L Sun, SCJ Yeung Cancer research 65 (9), 3671-3681, 2005 | 122 | 2005 |
| Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor–positive breast cancer E Fuentes-Mattei, G Velazquez-Torres, L Phan, F Zhang, PC Chou, ... JNCI: Journal of the National Cancer Institute 106 (7), dju158, 2014 | 119 | 2014 |
| Angiogenesis Inhibition in the in Vivo Antineoplastic Effect of Manumycin and Paclitaxel against Anaplastic Thyroid Carcinoma G Xu, J Pan, C Martin, SCJ Yeung The Journal of Clinical Endocrinology & Metabolism 86 (4), 1769-1777, 2001 | 119 | 2001 |
Liem Minh PhanThe University of Texas MD Anderson Cancer CenterVerifierad e-postadress på mdanderson.org
